Cambridge Investment Research Advisors Inc. Has $1.21 Million Stake in Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP)

Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP – Get Rating) by 19.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,445 shares of the company’s stock after buying an additional 2,555 shares during the quarter. Cambridge Investment Research Advisors Inc. owned about 0.37% of Invesco Dynamic Pharmaceuticals ETF worth $1,214,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Concourse Financial Group Securities Inc. acquired a new position in Invesco Dynamic Pharmaceuticals ETF during the fourth quarter worth $30,000. Credit Suisse AG acquired a new stake in shares of Invesco Dynamic Pharmaceuticals ETF in the second quarter valued at about $58,000. FMR LLC grew its position in shares of Invesco Dynamic Pharmaceuticals ETF by 622.2% in the second quarter. FMR LLC now owns 1,170 shares of the company’s stock valued at $88,000 after purchasing an additional 1,008 shares during the last quarter. Bank of Montreal Can grew its position in shares of Invesco Dynamic Pharmaceuticals ETF by 8.6% in the first quarter. Bank of Montreal Can now owns 2,359 shares of the company’s stock valued at $191,000 after purchasing an additional 187 shares during the last quarter. Finally, American Trust acquired a new stake in shares of Invesco Dynamic Pharmaceuticals ETF in the third quarter valued at about $227,000.

Invesco Dynamic Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:PJP opened at $76.00 on Friday. The company has a market cap of $304.75 million, a P/E ratio of 14.11 and a beta of 0.66. The stock’s 50-day moving average is $76.23 and its 200-day moving average is $77.50. Invesco Dynamic Pharmaceuticals ETF has a 52-week low of $68.59 and a 52-week high of $81.07.

About Invesco Dynamic Pharmaceuticals ETF

(Get Rating)

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.